BSE Live
Oct 31, 16:01Prev. Close
381.75
Open Price
388.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:40Prev. Close
384.30
Open Price
387.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
388.35 (30)
| Profit & Loss account of Kilitch Drugs (India) (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 57.02 | 95.57 | 49.95 | 27.20 | 20.82 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 57.02 | 95.57 | 49.95 | 27.20 | 20.82 | |
| Total Operating Revenues | 60.77 | 96.42 | 50.46 | 28.14 | 21.02 | |
| Other Income | 5.71 | 4.52 | 2.78 | 1.14 | 2.74 | |
| Total Revenue | 66.48 | 100.94 | 53.24 | 29.28 | 23.76 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 36.49 | 53.16 | 26.35 | 10.50 | 8.92 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.73 | -0.18 | -0.44 | 0.75 | -0.19 | |
| Employee Benefit Expenses | 5.65 | 5.23 | 4.22 | 3.27 | 3.42 | |
| Finance Costs | 0.72 | 0.38 | 0.00 | 0.00 | 0.00 | |
| Depreciation And Amortisation Expenses | 1.15 | 1.20 | 1.19 | 1.32 | 1.61 | |
| Other Expenses | 17.98 | 21.61 | 14.76 | 13.89 | 12.48 | |
| Total Expenses | 61.25 | 81.41 | 46.08 | 29.74 | 26.25 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5.22 | 19.52 | 7.16 | -0.46 | -2.49 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 5.22 | 19.52 | 7.16 | -0.46 | -2.49 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.70 | 4.29 | 0.33 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.07 | 0.52 | 0.63 | -0.42 | -0.44 | |
| Tax For Earlier Years | 0.00 | -0.05 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.77 | 4.76 | 0.96 | -0.42 | -0.44 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 4.46 | 14.77 | 6.20 | -0.04 | -2.05 | |
| Profit/Loss From Continuing Operations | 4.46 | 14.77 | 6.20 | -0.04 | -2.05 | |
| Profit/Loss For The Period | 4.46 | 14.77 | 6.20 | -0.04 | -2.05 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 2.89 | 10.06 | 4.68 | -0.03 | -1.55 | |
| Diluted EPS (Rs.) | 2.89 | 10.06 | 4.40 | -0.03 | -1.55 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.93 | 0.93 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 5.00 | 5.00 | 0.00 | 0.00 |
20.05.2025
Kilitch Drugs Consolidated March 2025 Net Sales at Rs 61.23 crore, up 36.61% Y-o-Y
20.05.2025
Kilitch Drugs Standalone March 2025 Net Sales at Rs 56.30 crore, up 43.87% Y-o-Y
28.02.2025
Kilitch Drugs Consolidated December 2024 Net Sales at Rs 56.17 crore, up 76.65% Y-o-Y
17.02.2025
Kilitch Drugs Standalone December 2024 Net Sales at Rs 46.51 crore, up 56.27% Y-o-Y